The financially motivated cybercriminal threat actor Storm-1175 operates high-velocity ransomware campaigns that weaponize ...

NEW YORK, NY - JUNE 23: Ronald Acuña Jr. #13 of the Atlanta Braves hits a solo home run in the third inning during the game between the Atlanta Braves and the New York Mets at Citi Field on Monday, ...

The CVSS‑9.3 vulnerability allows unauthenticated remote code execution on exposed Marimo servers and was exploited in the wild shortly after disclosure, Sysdig says.

Subnautica 2 has weathered the storm and has rescheduled its early access release. IGN reported today that the sequel to the underwater survival game will begin early access on PC and Xbox in May, ...

The 32 things we learned from Week 2 of the 2025 NFL season: 0. Number of NFL victories New Orleans Saints QB Spencer Rattler has in eight starts following Sunday's 26-21 loss to the undermanned San ...

Joshua started at GameRant in 2017 where he fell in love with a company that supports creativity, treats video games with the respect they deserve, and is complete with people whose passions match his ...

GameSpot may get a commission from retail offers. Subnautica 2 is officially heading to early access in May. As reported by IGN, Unknown Worlds studio head Steve Papoutsis sent out a message to his ...

Feel the thrill of the hunt and keep an eye out for the wild and wonderous species that are roaming the Canadian wilderness. Way Of The Hunter 2, formerly known as Next Hunting Adventure, is the next ...

Amid all the Subnautica 2 legal drama, developer Unknown Worlds and publisher Krafton have finally revealed a release window for the underwater exploration game. IGN reported Tuesday evening that ...

The biggest story of the week is a new massive supply chain breach, which appears to be unrelated to the previous massive supply chain breaches, this time of the Axios HTTP project. Axios was ...

A critical pre-authentication remote code execution (RCE) vulnerability in Marimo is now under active exploitation, leveraged ...

Placebo-adjusted mean weight loss of 16.3% (39 lbs) at 180 mg and 16.0% (37 lbs) at 240 mg at 44 weeks with no evidence of weight loss plateau in ACCESS II, demonstrating highest efficacy among oral ...